JENNA AINSWORTH: Open Payments
NPI 1346790417 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,020 in 210 payments from 21 companies in 2025. Trend: 2023 $2,588 · 2024 $2,872 · 2025 $4,020
Food & beverage: $3,038Honoraria: $700Education: $282
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 9 | $792 |
| ABBVIE INC. | 33 | $453 |
| UCB, Inc. | 24 | $356 |
| Janssen Biotech, Inc. | 14 | $343 |
| Mallinckrodt Hospital Products Inc. | 12 | $278 |
| Regeneron Healthcare Solutions, Inc. | 10 | $266 |
| Galderma Laboratories, L.P. | 22 | $237 |
| PFIZER INC. | 10 | $210 |
| Novartis Pharmaceuticals Corporation | 17 | $198 |
| E.R. Squibb & Sons, L.L.C. | 12 | $174 |
Products named: VTAMA, Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, ACTHAR, NEMLUVIO, Sotyktu.
Industry payments across MS — which companies pay providers there.
